Unlike fad diets or extreme exercise plans, these medications work with your bodys natural hormones to support appetite control, blood sugar regulation, and long-term health improvements
: , , As hopeful as this is, a few big questions remain, especially if we care about equity and not just headlines: - Will oral GLP-1s actually be covered by insurers and employers as long term therapy, instead of short weight loss sprints followed by predictable regain - How will pricing and step edits work when a patient has already been on an injectable for more than a year - Will these trials and future studies meaningfully include the diverse, underrepresented communities that carry a disproportionate burden of obesity, sleep apnea, and cardiometabolic disease : - Set expectations early: discuss obesity as chronic disease, and proactively plan for maintenance before stopping anything
Acta Pharmacol
Estimated incidence in the U.S
Cell 185 , 24782494.e2428 (2022)
Right now, the focus is largely on their role in managing diabetes and obesity, but the research is really starting to show some interesting possibilities for mood disorders
